ArticleCurrent treatment options in cardiovascular medicine2015
Fontan Liver Disease: Review of an Emerging Epidemic and Management Options.
Article in Current treatment options in cardiovascular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Fontan-Associated Liver Disease (FALD) in the EUROFontan Experience. An Insight into European Awareness.Pediatric cardiology · 2026Observational
- Fontan-Associated Liver Disease.Seminars in liver disease · 2025Review
- Pediatric Combined Heart-liver Transplantation: A Single-center Long-term Experience.Transplantation direct · 2024Article
- Poor correlation of 2D shear wave elastography and transient elastography in Fontan-associated liver disease: A head-to-head comparison.JGH open : an open access journal of gastroenterology and hepatology · 2023Article
- Gravity assistance enables liver stiffness measurements to detect liver fibrosis under congestive circumstances.World journal of hepatology · 2022Article
- Alcohol use is prevalent among adults with the fontan circulation but does not correlate with liver disease.International journal of cardiology. Congenital heart disease · 2022Article
- Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents.Abdominal radiology (New York) · 2021Article
- Liver function monitoring in Fontan-procedure patients: audit of current practice across South Wales.The British journal of cardiology · 2021Article
- Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.Congenital heart disease · 2019Article
- Pediatric Fontan Associated Liver Disease: Non-invasive Evaluation with Serologic Markers and Acoustic Radiation Force Impulse (ARFI) Elastography.Progress in pediatric cardiology · 2019Article
- Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy.Hepatology (Baltimore, Md.) · 2018Review
- Fontan-associated liver disease: Monitoring progression of liver fibrosis.Clinical liver disease · 2018Review
- MELD-XI Scores Correlate with Post-Fontan Hepatic Biopsy Fibrosis Scores.Pediatric cardiology · 2016Article
- Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.European heart journal · 2016 · on this mapReview
- An Emphasis on Screening to Detect Liver Cirrhosis and Hepatocellular Carcinoma in Patients Having Undergone the Fontan Procedure in Early Childhood.Case reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
opinion statementAdults with complex congenital heart disease that resulted in a Fontan procedure frequently experience late cardiac failure. Increasingly, liver disease is recognized as an important complication of single-ventricle anatomy and Fontan physiology; however, there is no consensus regarding liver evaluation in this population. Here, we review what is known about liver disease in this unique group and propose screening and prevention measures. We also review controversial treatment areas including assist devices and transplantation, with a review of outcomes in isolated heart and combined heart-liver transplant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.